Pathogenesis and Treatment of Coronary Heart Disease Based on Metabolic Abnormalities from the Perspective of "Damp-Turbidity and Phlegm-Rheum Type of Diseases"

This paper explores the pathogenesis and treatment of coronary heart disease (CHD) from the perspective of metabolic abnormalities, guided by the Traditional Chinese Medicine (TCM) theory of "Damp-turbidity and Phlegm-rheum Type of Diseases." It examines the intrinsic connection between metabolic abnormalities and these syndromes, as well as their close link to the development of CHD. Metabolic disorders are the physiological foundation for the occurrence and progression of CHD and represent the microscopic essence of pathological products such as dampness and phlegm. Therefore, addressing metabolic imbalances is essential in the treatment process. At the onset of the disease, therapies should focus on eliminating dampness, invigorating the spleen, regulating qi, and promoting blood circulation to improve sugar and lipid metabolism. When dampness lingers for a long time, treatments should aim to transform dampness, clear turbidity, regulate qi, and activate blood circulation to protect vascular endothelial damage. As the disease progresses, treatment should aim at resolving phlegm, removing blood stasis and coordinating the internal organs to restore the damaged heart function. In severe cases, treatment should focus on warming Yang, transforming water and tonifying qi to prevent the occurrence of complications such as heart failure.